News for hackers. Stuff that matters.
Re:Vitamin C kills tumor cells with hard-to-treat mutation i... by empath75 on Monday November 09, 2015 @10:53AM (#10533705)
Kind of depressing that the study to investigate vitamin c injections won't get funded because drug companies can't sell it.
Re:Vitamin C kills tumor cells with hard-to-treat mutation i... by epistasis on Monday November 09, 2015 @11:24AM (#10533900)
Well, it won't get funded by a company unless there's a profit incentive, however there's other funding avenues for clinical trials like this. Besides applying for grants (which is extremely slow and extremely time consuming), research institutions often have small amounts of funds for running a trial in house, especially for something like this which only involves a few gene tests and an inexpensive treatment.
Re:Vitamin C kills tumor cells with hard-to-treat mutation i... by macns on Monday November 09, 2015 @11:00AM (#10533743)
This. Article ends with: > But Cantley says it may be possible to make an oral formulation that reaches high doses in the blood—which may be one way to get companies interested in sponsoring trials.